← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 31, 2004Last known activity
Apr 10, 2023
Acquired by AstraZeneca on Jan 1, 2015
Timeline
1980s
- Jun 1, 1983
Inovio Pharmaceuticals— Founded
2000s
- Jun 1, 2009
VGX Pharmaceuticals, LLC— Acquired
2010s
- Jan 1, 2015
AstraZeneca— Acquired By
- May 2, 2016
Bioject Medical Technologies, Inc.— Acquired
Drugs by trial phase (59 distinct, 59 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (18 own, 2 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Anus Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cervical Intraepithelial Neoplasia
- Communicable Diseases
- Coronavirus Infections
- Dengue
- Glioblastoma
- Hematologic Neoplasms
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- HIV Infections
- Infections
- Influenza, Human
- Influenza in Birds
- Lassa Fever
- Leukemia
- Neoplasms
- Neoplasms, Squamous Cell
- Orthomyxoviridae Infections
- Papilloma
- Papillomavirus Infections
- Penile Neoplasms
- Prostatic Neoplasms
- Recurrence
- Respiratory Tract Diseases
- Respiratory Tract Infections
- RNA Virus Infections
- Severe Acute Respiratory Syndrome
- Squamous Cell Carcinoma of Head and Neck
- Squamous Intraepithelial Lesions of the Cervix
- Uterine Cervical Dysplasia
- Uterine Cervical Neoplasms
- Vaginal Neoplasms
- Virus Diseases
- Vulvar Neoplasms
Subsidiaries (2 direct, 2 total across the full acquisition tree)
Recent trials (50)
- NCT05781542CollaboratorPhase 1Apr 10, 2023
- NCT05430958Lead sponsorPhase 1Oct 31, 2022
- NCT05430958Study directorPhase 1Oct 31, 2022
- NCT05293249CollaboratorPhase 1May 19, 2022
- NCT04906629CollaboratorPhase 1Sep 1, 2021
- NCT04588428Lead sponsorPhase 2Jun 21, 2021
- NCT04588428Study directorPhase 2Jun 21, 2021
- NCT04642638Study directorPhase 2/Phase 3Nov 30, 2020
- NCT04642638Lead sponsorPhase 2/Phase 3Nov 30, 2020
- NCT04367675CollaboratorPhase 1Sep 30, 2020
- NCT04447781CollaboratorPhase 1/Phase 2Jul 15, 2020
- NCT04398433Lead sponsorPhase 1/Phase 2May 31, 2020
- NCT04398433Study directorPhase 1/Phase 2May 31, 2020
- NCT04336410Study directorPhase 1Apr 3, 2020
- NCT04336410Lead sponsorPhase 1Apr 3, 2020
Details
- Founded
- Blue Bell, PA, US Jun 1, 1983
- Last known activity
- Apr 10, 2023